Daniel Calvert

Daniel Calvert has worked in a variety of roles in the life sciences industry. From 2011 to 2013, they were an Account Executive at National Funding and a Marketing Consultant at TorreyCove Capital Partners LLC. In 2014, they became the Director of Business Development at Parallel 6, where they were an integral member of the team that led to the acquisition of the organization and its Mobile Health Platform to PRA Health Sciences. In 2018, they were a Business Development Manager at Almac Group. From 2019 to 2021, they were the Director of Business Development at Signant Health and eCOA. Currently, they are the Sales Director, Life Sciences at Deep 6 AI, where they apply AI methods on structured and unstructured patient data to match patients and sites to actual trial protocols.

Daniel Calvert received their Bachelor of Science (BS) in Business Management Specializing in Entrepreneurship from San Diego State University.